行情

ASLN

ASLN

Aslan Pharms
NASDAQ

实时行情|Nasdaq Last Sale

2.360
-0.130
-5.22%
盘后: 2.360 0 0.00% 17:20 12/06 EST
开盘
2.490
昨收
2.490
最高
2.490
最低
2.110
成交量
153.83万
成交额
--
52周最高
8.18
52周最低
0.3500
市值
7,912.09万
市盈率(TTM)
-2.6514
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ASLN 新闻

  • ASLAN Pharmaceuticals Announces Closing of US$15 Million Public Offering of American Depositary Shares, Including Full Exercise of Underwriter’s Option to Purchase Additional ADSs
  • GlobeNewswire.1天前
  • GPRO, CLVS among premarket gainers
  • Seeking Alpha - Article.2天前
  • Aslan Pharmaceuticals stock plunges after stock offering prices at a 52% discount
  • MarketWatch.3天前
  • Mid-Afternoon Market Update: DarioHealth Jumps On Walmart Distribution Deal; Cara Therapeutics Shares Plummet
  • Benzinga.3天前

更多

所属板块

制药
+0.11%
制药与医学研究
+0.32%

热门股票

名称
价格
涨跌幅

ASLN 简况

ASLAN PHARMACEUTICALS LIMITED is a company engaged in the research and development of new pharmaceuticals. The Company locates its headquarters in Singapore and set up outposts in Taiwan, China and Australia to create a cross-regional platform. Through this platform, the Company is authorized to introduce pharmaceuticals from international pharmaceutical factories and biotechnology companies and it is also involved in the later production and clinical activities. The Company owns five products at the research and development stage which are mainly targeted at indications including biliary tract, gastric, breast and colorectal cancers.
展开

Webull提供Aslan Pharmaceuticals Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。